ReviewCancer innovation2024
TRIP13: A promising cancer immunotherapy target.
Shengnan Jing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
8 papers cite it
this papercites it
ReviewCancer innovation2024
Shengnan Jing et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.